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(VEGF) and monocyte chemoanractant protein-l (MCP-1) levels were measured by 
ELISA. The number of circulating endothelial progenitor cells (EPC) was determined by 
FACS analysis. Conclusion?.: SHS stimulates tumor growth, tumor angiogenesis, and the 
number of circulating endothelial progenitor cells. These effects were reduced by the nic- 
otinic receptor antagonist mecamylamine Indicating an important role for nicotine; and 
were reduced by cerivastatin which together with reduced MCP-1 levels suggests a 
strong anti-inflammatory effect. 
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transduction. CM was added to endothelial (EC) and smooth muscle (SMC) cell cultures 
to a?sess proliferation. When compared to CM from MSC’s under normoxia or hypoxia, 
CM from transduced MSCs increased EC (290% vs 31% vs 79% compared to control 
media, p<O.OOl) and SMC (220% vs 26% vs 56%, p<O.OOl) proliferation. CM from trans- 
duced cells enhanced tube formation on Matrigel plates compared to control or MSC 
media. Conclusion?.: Constitutive over-expression of HIF-la/VP-l6 augments In-vitro 
angiogeniclarteriogenic effects of MSCs and may represent a novel approach for thera- 
peutic angiogenesis. 
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830-4 MCP-1 Induces a Sustained Arteriogenic Response in 
ApoE Mice but Accelerates Atherosclerotic Plaque 
Development 
Niels van Roven, Imo Hoefer. Markus Boeninger, Jing Hua, Sebastian Grundmann, 
Mlchiel Voskuil. Christooh Bode. Wolfaano Schaoer. Ivo R. Buscchmann. Jan J. Piek. 
Academic Med/cal Cenier, University of A&terd& Amsterdam, The Netherlands, 
University of Freiburg, Freiburg, Germany 
Introduction: Monocyte Chemoanractant Protein-l (MCP-1) increases the formation of a 
collateral circulation upon arterial occlusion. The present study served to determlne 
whether these pro-arteriogenic properties of MCP-1 are preserved in hyperlipidemic 
ApoE -I- mice and whether it affects systemic development of atherosclerosis. 
Methods: 72 ApoE -/- mice were treated with low dose MCP-1 (1 pS/kg/week), high dose 
MCP-1 (10 pg/kg/week) or Phosphate Buffered Saline (PBS) as control after unilateral 
ligation of the femoral artery. Collateral flow was measured using fluorescent micro- 
spheres. In addition, monocytic Cdllb expression was measured by FACS-analysis. 
The number of adhering monocytes. neointlma formation and cellular plaque composi- 
tion were determined histologically. Total plaque surface was quantified after Sudan IV 
taining. 
Results: Collateral hindlimb flow significantly increased upon high dose MCP-1 treatment 
(PBS: 22.6% * 7.2%, MCP-1: 31.3% f 10.3%, pcO.05). These effects were still present 
two months after the treatment (PBS: 44.3% * 4.6%, MCP-1: 56.5% * 10.4%. pcO.001). 
However, an increase was observed for systemic CD1 1 b expression by monocytes. 
monocyte adhesion at the aortic endothelium and neointima formation (PBS: 0.097 * 
0.011 vs. MCP-1: 0.257 * 0.022, intimafmedia ratio, p<O.OOOl). Moreover an IncreaSe in 
aortic atherosclerotic plaque surface was observed (PBS: 24.3% * 5.2% vs. MCP-1: 
36.2% * 9.5%, p<O.Ol) as well as a significant decrease in the percentage of smooth 
muscle cells (control: 15.0% + 5.2% vs. 5.6% * 2.3%, p<O.OOOl). 
Conclusion: Local infusion of MCP-1 significantly increases collateral flow upon femoral 
artery legation in ApoE -/- mice up to two months after the treatment. The local treatment 
however did not preclude systemic effects on atherogenesis. showng an increase in 
monocyte adehesion to aortic endothelium as well as increased neointima formation. 
Moreover, the local MCP-1 treatment induced changes in cellular content of plaques. 
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830-5 Exposure to Second Hand Smoke Stimulates 
Angiogenesis in Tumors 
Boaina Zhu, Christopher Heeschen, Richard E. Sievers. Stanton A. Glantz, Kanu 
Chanerjee, William W. Parsley, John P. Cooke, University of California San Francisco, 
San Francisco, CA, Stanford University, Stanford, CA 
Background: Exposure to second hand smoke (SHS) Increases the incidence of athero- 
sclerosis, cardiovascular death, and lung cancer. Pathological angiogenesis plays a role 
!n the growth of atheroma and tumor. Methods: To investigate the effects of SHS on 
angiogenesis we used a murine Lews lung cancer model. SHS groups were exposed to 
SHS (4 cigarettes/l5 men, 6 hours/day). Non-SHS groups were exposed to fresh air. 
Mice were randomized (n=6, each group): two non-SHS groups (control and cerivastatln 
[2.5 mglkg, HMG-CoA reductase Inhibitor]) and three SHS groups (control, cerivastatin, 
and mecamylamine IO.5 g/kg. nicotinic acetylchollne receptor antagonist]). After 6 days, 
all mice were sacrificed due to excesswe tumor growth in the control arm of the SHS 
group. Tumor size was determined with a digltal c&per. Angiogenesis was determined 
by infusion of space-filling fluorescent mlcrospheres. Vascular endothelial growth factor 
Treatment 
Tumor size (cm) 
Tumor weight (g) 
Capillaries/mm2 
VEGF (pg/ml) 
MCP-1 (no/ml) 
EPC (%) 
:sults (* PC0 01 as compared with Non-SHS control group) 
Non-SHS Non-SHS SHS SHS SHS 
Control Cerivastatin Control Cenvastatin Mecamylamine 
0.25*0.0 0.17ztO.04 1.31*0.44’ 0.59*0.14’ 0.66+0.29’ 
5 
0.17*0.0 0.11+0.03 0.93*0.27’ 0.35*0.13’ 0 34+0.12’ 
4 
4.6k1.9 3.9il.4 6.5t2.3 5.6i1.6 4.9*2.3 
50*16 39*9 139+23 121*16 73*29 
5.9ztl.2 4.6t0.6 14.2zt2.5’ 6.9+1.6 12.1+2.3’ 
l.OiO.2 1.3*0.3 3.9*0.4* 2.6+0.4’ 2.1+0.4’ 
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830-6 Vascular Endothelial Growth Factor Induces Both 
Angiogenesis and Arteriogenesis Independently of 
Nitric Oxide 
Timothv J. Chico, Joan Grew, Hope Steinmetz. John Hoeflel, Ann Daugherty, Simon P. 
Williams, Stuart Bunting, Nicholas Van Bruggen, Genentech Inc., South San Francisco, 
CA 
Background. Vascular Endothelial Growth Factor (VEGF) is a potent angiogenic factor, 
though its effect on larger vessels (arteriogenesis) is unclear. Nitric oxide (NO) is sug- 
gested to mediate the effects of VEGF. We therefore evaluated the effect of exogenous 
VEGF on angiogenesis, arteriogenesis, and tissue perfusion with and without NO syn- 
thase inhibition. 
Methods. 8-12 week old male C57 mice were treated chronically with oral L-NAME (a 
NO synthase inhibltor) or control from one week before until the end of the study. Mice 
were injected into the left calf with murine VEGF or vehicle 7d after starting L-NAMElcon- 
trol. Arteriogenesis was assessed using Magnetic Resonance Angiography (MRA) 1, 3 
and 5 days after injection. AnglogenesIs was assessed 7d after injection by histology and 
radiolabelled anti-PECAM binding. Regional blood flow to the calf was measured using 
radiolabeled microsphere deposition either in the resting state or after 1Om1n electrical 
sciatic nerve stimulation (4V 8 4Hz) to simulate exercise-induced flow recruitment. Sta- 
tistical comparisons were by ANOVA. 
Results. Followlna VEGF treatment an increase in caoillarv densitv was observed hIsto- ._ , 
logically. Calf endothelral cell density was increased by 166% compared to control 
1~~0.051. MRA revealed a time-deoendent increase in anaioaraohicallv detectable ves- ,, 1 1 1  _  
sels proximal to the Injected region. VEGF increased both resting calf blood flow (129+20 
vews 13*2 ml/min1100g, ~~0.05) and calf blood flow after sciatic nerve stimulation 
(167+21 versus 80+29 ml/mln/lOOg, ~~0.05). These increases were confined to the 
region injected and were not seen in the thigh or foot. Chronic L-NAME treatment had no 
effect on either endothelial cell density or the angiographic appearance of vehicle and 
VEGF treated groups. The VEGF-induced increase in resting blood flow was, however 
completely abolished by L-NAME (1913 ml/min/lOOg). 
Conclusions. Exogenous VEGF increases both anglogenesIs and the size of larger ves- 
sels supplying the injected region. While NO mediates the increase I” blood flow associ- 
ated with these changes, the effects of VEGF on vascular remodelling at both the 
capillary and arterial level do not require intact NOS. 
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832-1 Sildenafil Improves Endothelial Dysfunction in Treated 
Hypertensive Heart Transplant Recipients 
Juan Estrada. Rahul Aggawal, David G. Edwards, Brian T. Schuler, Richard S. 
Schofield, Juan M. Aranda. Jr., James A. Hill, Wilmer W. Nichols, University of Florida, 
Gainesville, FL 
Background: Flow-mediated dilation (FMD) during reactive hyperemia is an Index of 
nitric oxide (NO) dependent endothelial function and is reduced in heart transplant recip- 
ients. NO reduction IS associated wth decreased production of cyclic guanosine mono- 
phosphate (cGMP). Sildenafil. a type 5 phosphodiesterase Inhibitor. may enhance the 
production of cGMP, increase the release of NO and improve endothelial dysfunction. 
Accordingly, the aim of this study was to determine the effects of sildenafil on brachial 
